Sites participating in clinical trials play a crucial role in their conduct and delivery. We rely on the expertise, patient engagement and commitment of site staff to promote our research and recruit effectively, so that we improve outcomes for patients with GI cancer.
The Excellence in Site Performance Awards recognise clinical trial sites that have shown exceptional enthusiasm, performance and dedication to conducting GI Cancer Trials studies.
There are two categories:
All clinical trial sites actively involved in GI Cancer Trials studies are encouraged to apply.
The successful sites will be announced at the 28th ASM in Nipaluna / Hobart. The recipients will receive two complimentary registrations to attend next year's ASM, recognition of achievement on the GI Cancer Trials website, member newsletter, and kudos from within the GI Cancer Trials network.
For any enquiries, please contact GI Cancer Trials.
Submission deadline: Monday 28 September 2026, 9:00am AEST
Sites will be judged on the following criteria:
2025 recipients

2025 Metropolitan recipient:
Austin Health Cancer Clinical Trials GI Team
The award was accepted by Meg Donovan-Hayes and Professor Niall Tebbutt.

2025 Regional, Rural & Remote recipient:
Sunshine Coast University Hospital
The award was accepted by Dr Michael Allen.
2024 recipients
2023 recipients
St John of God Hospital Subiaco (Metropolitan) & Illawarra Shoalhaven Local Health District (RRR)
2022 recipients
Royal Brisbane and Women’s Hospital (Metropolitan) & Bendigo Health (RRR)
Past Outstanding Site Award recipients (Prior to the Award Renaming)